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The yolk sac is phylogenetically the oldest of the extraembryonic membranes. The 
human embryo retains a yolk sac, which goes through primary and secondary phases of 
development, but its importance is controversial. Although known to synthesize proteins, 
transport functions are widely considered vestigial. Here, we report RNA-Seq data for 
the human and murine yolk sacs, and compare with data for the chicken. We also relate 
the human RNA-Seq data to proteomic data for the coelomic fluid bathing the yolk sac. 
Conservation of transcriptomes across the species indicates that the human secondary 
yolk sac likely performs key functions early in development, particularly uptake and 
processing of macro- and micronutrients, many of which are found in coelomic fluid. 
More generally, our findings shed light on evolutionary mechanisms that give rise to 
complex structures such as the placenta. We identify genetic modules that are 
conserved across mammals and birds, suggesting these are part of the core amniote 
genetic repertoire and are the building blocks for both oviparous and viviparous 
reproductive modes. We propose that although a choriovitelline placenta is never 
established physically in the human, the placental villi, the exocoelomic cavity and the 





The human yolk sac is often considered vestigial. Here, we report RNA-Seq analysis of 
the human and murine yolk sacs, and compare with that of the chicken. We relate the 
human RNA-Seq data to coelomic fluid proteomic data. Conservation of transcripts 
across the species indicates the human secondary yolk sac likely performs key functions 
early in development, particularly uptake and processing of macro- and micronutrients, 
many of which are found in coelomic fluid. More generally, our findings shed light on 
evolutionary mechanisms giving rise to complex structures such as the placenta. We 
propose that although a choriovitelline placenta is never established physically in the 
human, the placental villi, exocoelomic cavity and secondary yolk sac function together 





The yolk sac is phylogenetically the oldest of the extraembryonic membranes, evolving 
in anamniotes to absorb nutrients from their lipid-rich megalecithal eggs (1). Although the 
ova of eutherian mammals are microlecithal, the yolk sac has been recruited to transport 
maternal nutrients during earliest stages of embryonic development. In the majority of 
species, it makes contact with the chorion to form a transient choriovitelline placenta. 
This functions during the critical period of organogenesis, at the end of which its 
functions are generally subsumed by the definitive chorioallantoic placenta. There is, 
however, considerable species variation, and the most elaborate development is found 
in rodents and lagomorphs. In these, the yolk sac continues to transport nutrients and 
immunoglobulins throughout gestation in parallel with the chorioallantoic placenta. For 
this reason, most of the experimental data on transport have been obtained in the 
mouse, rat and guinea pig (2-6), and data on the human yolk sac are limited. 
 
The human yolk sac goes through two developmental phases: a primary yolk sac which 
develops between embryonic days 7 and 9 and is replaced by a secondary yolk sac 
which is active until day 49 (7). The role of the primary yolk sac is unknown. The 
importance of the secondary yolk sac remains controversial. Although it is known to 
synthesize proteins, such as alpha fetoprotein, its transport functions are widely 
considered vestigial. Primarily, this is because the secondary yolk sac never makes 
contact with the chorion to form a choriovitelline placenta. Instead, it floats in the 
exocoelomic cavity, connected to the embryo by the vitelline duct. Although we, and 
others, have speculated that the yolk sac plays a critical role during organogenesis (3-5, 
8-10), there are limited data to support this claim. Obtaining experimental data for the 
human is impossible for ethical reasons, and thus we adopted an alternative strategy. 
Here, we report RNA-Seq data derived from human and murine yolk sacs, and compare 
them with published data from the yolk sac of the chicken. We postulate that 
conservation of transcripts across these species indicates retention of key transport and 
synthetic functions. We support this hypothesis by comparing the human yolk sac 
transcriptome with the proteome of the coelomic fluid. 
 
Results and Discussion 
We determined the transcript profile for the first trimester human yolk sac by RNA-Seq 
with a median sequencing depth of 39 million mapped reads per sample (n=9, SI 
Appendix Table S1). We identified 12469 transcripts with a mean RPKM (Read Per 
Kilobase Per Million Mapped Reads) ≥1 (Dataset S1). Similarly, we identified 11628 
transcripts in first trimester human placental villous samples (n=11, median sequencing 
depth 30 million mapped reads, Dataset S2) and 11272 transcripts in the mouse yolk sac 
(n=8, median sequencing depth 28 million mapped reads, Dataset S3). 
 
In addition, we investigated the protein composition of the coelomic fluid using GELC-
MS/MS. We focused on the 165 proteins identified in any 4 of the 5 samples having 
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excluded immunoglobulins (Dataset S4). Proteins were mapped to unique Ensembl 
gene identifiers, which were used to identify over-represented GO terms (Dataset S5). 
 
Cholesterol 
We selected the 400 most abundant human yolk sac transcripts and identified enriched 
gene ontology (GO) terms using Panther (complete reference database with Bonferroni 
correction, Dataset S6). Several terms associated with lipid transport were enriched, for 
example “very-low-density lipoprotein particle” (23 fold, P=4.5x10-7). Indeed, “cholesterol” 
featured in many of the enriched “biological process” terms (Figure 1). Cholesterol is 
required for development (3, 5) as it maintains integrity of cell membranes (11), mediates 
metabolism through propagation of signaling pathways (12), and is the precursor for 
steroid hormones. In addition, activity of sonic hedgehog (SHH) proteins, which are 
responsible for the development of the central nervous system (13-15) is determined by 
covalent modification with cholesterol and other lipids (16). During organogenesis, the 
embryo is reliant on maternal sources of cholesterol until its liver is sufficiently mature for 
synthesis (4, 17). Our data show that the human yolk sac contains abundant mRNAs 
encoding multiple apolipoproteins, the cholesterol efflux transporter ABCA1, as well as 
lipoprotein receptors, including megalin, cubilin (18), albeit at lower levels (Figure 1). 
Also present are transcripts encoding all classes of ABC transportors (A to G), which, in 
addition to transporting cholesterol and lipids, facilitate excretion of toxins and confer 
multidrug resistance (Table 1). The high abundance (i.e. top 0.5%) of transcripts 
encoding apolipoproteins present in lipoprotein particles and chylomicrons (ApoB, 
ApoA1, ApoA2 and ApoA4) is matched by the high levels of these proteins in the 
coelomic fluid (Dataset S4). Indeed, most of the proteins found in coelomic fluid are 
highly ranked in the RNA-Seq data (although some were undetectable, i.e. below the 
RPKM ≥ 1 threshold). Many of these proteins have functions associated with cholesterol 
or lipid transport and metabolism (Figure 2). 
 
APOB is an essential apolipoprotein found in VLDL particles and chylomicrons. In the 
latter, which are assembled in enterocytes, the APOB transcript is edited by a cytidine 
deaminase (APOBEC1, apolipoprotein B mRNA editing enzyme catalytic subunit 1) to 
introduce a stop codon leading to the production of a short form of the apolipoprotein 
(APOB-48). The APOB transcripts in the human secondary yolk sac are all of the 
unedited hepatic form and the APOBEC1 transcript was not detected. Transcripts 
encoding other proteins required for lipid transport (19) are also abundant, for example, 
the LDL receptor (LDLR) and microsomal triglyceride transfer protein, MTTP, are in the 
top 10% and 20 %, respectively. This would suggest that the secondary yolk sac plays a 
role in facilitating the transport of maternal lipids and cholesterol to the fetal 
compartments before vascularization of the placental villi is fully established. 
 
The fluid of the exocoelom shares many proteins in common with maternal plasma, 
supplemented by the addition of specific decidual, trophoblastic and yolk sac proteins. 
Analogous to maternal serum proteins (20), coelomic fluid proteins can be broadly 
categorized into common circulating proteins, coagulation and complement factors, 
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blood transport and binding proteins, protease inhibitors, proteases and other enzymes, 
cytokines and hormones, channel and receptor-derived peptides and miscellaneous (SI 
Appendix Table S2) (21, 22). 
 
Transport 
The secondary yolk sac comprises an outer mesothelial epithelium and an inner 
endodermal layer, separated by dilated capillaries and a small amount of mesoderm (23). 
Both the mesothelial and endodermal epithelia display ultrastructural features typical of 
an absorptive epithelium, including numerous microvilli, coated pits and pinocytotic 
vesicles. The GO term “transport” (GO:0006810) was overrepresented in the top 400 
yolk sac transcripts (2.87 fold, p=7.16 x 10-47). Many such annotated transcripts were 
present in the most abundant 20% of transcripts (87) (Dataset S5). Most of these 
transporter genes are members of the solute carrier (SLC) family of transporters (for 
example: SLC38A2 (amino acids), SLC4A1 (anions), SLC20A1 (phosphate) and 
SLC25A37 (iron in the mitochondria)). Transcripts encoding 259 SLC transporters were 
identified (mean RPKM ranged from 134 to 1). We classified these transporters into 11 
main groups on the basis of substrate category (24), i.e. amino acids, urea cycle, 
glucose, nucleoside sugars, metals, vitamins, neurotransmitters, inorganic ions, thyroid, 
organic ions, and miscellaneous, and matched them to their main substrates that we and 
others (21, 22, 25-35) have identified in coelomic fluid samples (Table 2). Zinc is the 
second most abundant trace element, and is critical for embryonic development. It plays 
a role in numerous biological processes, including cell division, growth and differentiation 
and acts as a structural, catalytic and regulatory component within transcription factors, 
enzymes, transporters and receptors (36, 37). Absorbed zinc is mostly bound to albumin 
and α2-macroglobulin, both of which are abundant in coelomic fluid. In humans, zinc 
transport is mediated by 14 members of the ZIP family (SLC39A) and 10 members of the 
ZnT family (SLC30A). We detected mRNAs encoding 12 ZIP proteins and 8 ZnT proteins 
in the secondary yolk sac. Immunostaining for the zinc transporter SLC39A7/ZIP7 was 
present in both the inner endodermal and outer mesothelial epithelia, suggesting uptake 
from the coelomic fluid and transport to the fetal circulation (Figure 3). The outer 
mesothelial layer also expresses α-tocopherol transport protein to facilitate vitamin E 
transport (38). Thus, our data suggest the human secondary yolk sac has a role in the 
transport of multiple nutrients and vitamins, including iron (seven iron-transporting SLC 
transcripts identified, Table 2) (39, 40), vitamins A, B12, C, E, and folic acid (Table 2). 
 
Total protein concentration is lower in coelomic fluid than in maternal plasma. However, 
most amino acids are at higher concentrations and must be derived from the villi and/or 
the yolk sac. This suggests that the coelomic cavity is an important route for metabolites 
required for embryonic development (25). The secondary yolk sac floats within this 
nutrient-rich milieu. It is therefore possible that uterine secretions supplemented by 
maternal plasma from spiral arteries are taken up by the trophoblast cells, passed via the 
villous stromal channels into the exocoelomic cavity, from which they are taken up by the 
yolk sac and transferred to the embryonic gut and the fetal circulation via the vitelline 
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duct (38). Thus, there appears to be free interchange between these two compartments 
of the human gestational sac. 
 
The passage across the trophoblast may require lysosomal digestion of macromolecules, 
and indeed the GO term “lysosome” (GO:0005764) is enriched 4-fold within the most 
abundant 400 villous transcripts (Bonferroni corrected P=7.99 x10-9). The efflux amino 
acid transporters SLC43A2 and SLC7A8 are also highly expressed (above the 95th and 
83rd centiles, respectively). In the rat it has been estimated that ~95% of the amino acids 
provided to the fetus in mid-gestation are obtained by lysosomal digestion of 
endocytosed maternal proteins (2). In the mouse yolk sac, transcripts encoding 5 
lysosomal cathepsins (Ctsl, Ctsz, Ctsb, Ctsd and Ctsh) are among the most abundant 
400 transcripts, the activity of which would allow for degradation and release of free 
amino acids to the developing fetus. We have previously shown that the mesothelial 
layer of the human yolk sac stains for glycodelin, a product of the uterine glands and 
present in high concentration in the coelomic fluid (41), indicating exposure to intact 
maternal proteins and uptake (42). Glycodelin also colocalizes with lysosomal Cathepsin 
D in human first trimester villi (43). As in the mouse, several cathepsin transcripts (CTSB, 
CTSZ, CTSL and CTSD) are extremely abundant in the human secondary yolk sac. We 
found that the GO term “lysosome” is enriched in the list of most abundant transcripts 
from yolk sacs of human, mouse and chicken (2.79 fold P=1.35-3; 3.53 fold P=9.72-5 and 
3.6 fold P=2.13-3, respectively), indicating a similar capacity for digestion of endocytosed 
macromolecules. 
 
These findings indicate that the exocoelomic cavity is a physiological liquid extension of 
the early placenta (44), and that the yolk sac is an important route of access for high 
molecular weight proteins to the embryonic circulation (45). 
 
Hematopoiesis 
In all vertebrates, primitive embryonic and definitive fetal/adult blood cells form 
successively within the yolk sac, fetal liver and bone marrow (46). The human secondary 
yolk sac is the sole site of hematopoiesis for the first two weeks of pregnancy, and the 
fetal liver commences blood cell production at week 6 of gestation (47, 48). The term 
“hemoglobin complex” was significantly enriched among abundant yolk sac transcripts 
(33 fold, P=2.95 x10-6). The yolk sac produces predominantly nucleated erythrocytes, 
which synthesize embryonic hemoglobin (HBZ). There is morphological evidence of the 
first blood islands in the secondary yolk sac at about day 18 of gestation (49). Yolk sac-
derived primitive erythrocytes have been detected in the cardiac cavity as early as the 3-
somite stage (21 days), indicative of an established functional network between the yolk 
sac and embryo (50). The human yolk sac, like that of the mouse, also produces 
macrophage and multipotential hematopoietic progenitors (48). 
 
Transcription factors 
Within the most abundant 400 transcripts in the human yolk sac, 19 genes are annotated 
as "regulation of transcription, DNA-templated" (GO:0006355), including several 
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transcription factors (ATF4, FOS, JUN, JUNB and JUND.)  In the mouse data set, 8 
genes are similarly annotated (SI Appendix Table S3). Candidate motifs recognized by 
these transcription factors (where known) were identified in the 1kb and 5kb upstream of 
the TSS of genes which were the highly correlated with the transcription factor 
transcripts (Datasets S7-10). The FOS and JUN families and AFT4 are closely related, 
functionally interact, have multiple target genes and are widely expressed. There are 
numerous candidate binding sites in the highly expressed human yolk sac genes (181 
genes with sites for the FOS and JUN families and ATF4, Datasets S7, 8) and 18 genes 
in the mouse with candidate Atf4 binding sites (Datasets S9, 10). The evidence used for 
the assignment of GO terms varies and for 2 genes (IGF2 and BHLHE40) depends on a 
Non-traceable Author Statement (NAS, Dataset S3). Furthermore, binding motifs are not 
available for all candidate factors even in the most recent JASPAR database. 
 
Yolk sac and villi compared to adult lung, liver and kidney  
The inaccessibility of the human yolk sac severely constrains any functional investigation 
of these candidate transcription binding sites. We therefore compared the human yolk 
sac transcript profile with tissues where function has been better defined experimentally. 
The placental villi serve similar functions to the adult lung, liver and kidney, and we 
therefore compared the overlap among the 400 most abundant transcripts from these 
tissues and the yolk sac (Figure 4). The transcripts that are unique to each tissue and 
those shared among these tissues are listed in Dataset S11. As expected, the transcripts 
shared by all 5 tissues encoded abundant house-keeping proteins, such as ribosomal 
proteins and those involved in mitochondrial energy generation with GO terms such as 
“cytosolic small ribosome subunit”, “cytosolic large ribosome subunit” and “mitochondrial 
respiratory chain” being significantly overrepresented (P< 8.5x10-8 after Bonferroni 
correction, Dataset S12). The enriched GO terms associated with the 35 transcripts 
shared only by the yolk sac and liver include “high-density lipoprotein particle receptor 
binding”, “cholesterol transporter activity”, “lipid transporter activity” (all greater than 28-
fold enrichment and P< 2x10-4 after Bonferroni correction, Dataset S13).  
 
We also examined the overlap among over-represented GO terms in the most abundant 
transcripts in these 5 tissues (Supplementary Datasets S6, 14-17). For example, the 
Biological Process terms "high-density lipoprotein particle remodeling", "lipid transport", 
"cholesterol efflux", and "cholesterol metabolic process" are all overrepresented and 
shared between the yolk sac and liver (Figure 5, Datasets S18-20). It is striking that 
among the shared transcripts many (18 of 35) encode proteins with transport capacity. 
Besides the lipid and cholesterol transport-associated genes (APOA1, APOA2, APOA4, 
APOB, APOC1, APOC3 and APOH), the major serum carriers of corticosteroids and 
progesterone (SERPINA6) are present. In addition, the thyroxine (T4) hormone carrier 
(SERPINA7 also known as TBG, and TTR) was detected. Maternal thyroxine is essential 
for fetal brain development prior to the commencement of fetal thyroid function at the 
end of the first trimester (26). Furthermore, transcripts encoding several metal binding or 
transporting proteins are present (MT1E, MT1H, TF, HPX and SEPP1). The latter is a 
selenoprotein which contains 10 selenocysteine residues per molecule, and is 
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postulated to function as a carrier of selenium (51). These data indicate that the yolk sac 
shares many abundant transcripts with other metabolically active fetal and adult tissues, 
and that it contains transcripts that encode several liver specific functions, including 
those encoding several essential hormone transporters. 
 
Mouse Yolk Sac RNA-Seq data 
On a comparative basis, the yolk sac provides an important pathway for nutrient uptake 
in many species during early pregnancy (52, 53), and its role has been well documented 
in experimental rodents, such as the rat and mouse (54). At the ultrastructural level, the 
endodermal layers of the human and rodent yolk sacs display many similar 
morphological characteristic typical of an absorptive epithelium (10, 55). However, their 
orientation is different as the human yolk sac floats in the exocoelom with the 
endodermal cell layer lining the interior of the sac, whilst the rodent yolk is inverted with 




To compare the most abundant transcripts in the human, mouse and chicken yolk sac 
we identified the homologous genes by mapping the human Ensembl gene identifiers to 
the corresponding mouse and chicken Ensembl gene IDs using biomart (release 
ENSEMBL Genes 85) Dataset S20. The raw and processed chicken yolk sac data were 
obtained directly from the authors (58). Gene ontology analysis was carried out as 
described above, using the 400 most abundant chicken yolk sac transcripts observed at 
E17 (Dataset S22). The intersection between the over-represented GO terms in the 
human, mouse and chicken yolk sacs was determined as described above (SI Appendix 
Table S4). Venn diagrams showing the overlaps are shown in Figure 6. The P values for 
all the observed intersections are highly significant (P< 1.70x10-22 and are summarized 
in Dataset S23). The depth of the GO annotation varies between species and is more 
limited in the chicken, which necessarily precludes detecting a high degree of overlap 
with the human genes. Nonetheless, shared biological process terms include 
“translation”, “ribosome biogenesis”, “oxidation-reduction process” and “small molecule 
metabolic process” reflecting cellular processes associated with metabolically active 
tissue. Transcripts reflecting more specialized cellular function, such as lipid and 
cholesterol transport, which are shared by the human yolk sac and liver (APOA1, 
APOA4, APOB, RBP4, SEPP1, TTR) are also present among the 400 most abundant 
mouse and chicken yolk sac transcripts (P=2.3 x10-13). 
 
Conclusion 
Overall, our data show that the human secondary yolk sac appears far from vestigial with 
little or no biological role, and that it may perform many key functions in the early weeks 
of development. In particular, it contains abundant transcripts encoding an array of 
transporter proteins involved in the uptake of macro- and micronutrients. Our data 
showing the presence of transporter proteins in both of the yolk sac epithelia, and their 
substrates in coelomic fluid, support this concept and are consistent with the 
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morphological appearances of absorptive surfaces (23, 59, 60). Our data also confirm 
significant synthetic activity, especially of apolipoproteins, a function most likely 
performed in the endodermal cells given their high content of endoplasmic reticulum and 
Golgi cisternae (23, 59, 60). The handling of cholesterol, which is essential for synthesis 
of cell and organelle membranes as well as being a co-factor in signaling pathways 
involved in axis determination and other fundamental developmental events, appears of 
particular significance. Furthermore, the high level of conservation of transcripts 
compared with the mouse and the chicken, where the yolk sac is known to be essential 
for development, suggests maintenance of function. 
 
The secondary yolk sac is thus likely to be essential for the survival of the embryo during 
the first weeks of development. Morphological abnormalities of the secondary yolk sac 
have been reported in 70% of first trimester human miscarriages (61), but separating 
cause from effect is impossible.  
 
More generally, our findings shed light on the evolutionary mechanisms that give rise to 
complex structures such as the placenta. The placenta has evolved repeatedly from an 
oviparous background in mammals, reptiles and fish, sometimes over very short 
timescales (62, 63). Development of a yolk sac for direct maternal provisioning of the 
developing fetus is a common feature of such evolutionary transitions to the extent that 
the yolk sac may be regarded as a "fundamental vertebrate fetal nutritional system" (64). 
The yolk sacs studied in this paper constitute a broad, albeit incomplete, sampling of the 
variation present in the vertebrates. The inverted yolk sac placenta of the mouse is found 
in several rodents and lagomorphs (1), but also in the distantly related nine-banded 
armadillo (65). The "free floating" secondary yolk sac of the human is found in the other 
haplorhine primates (Macaca mulatta) (66) but also, surprisingly, in distantly related 
Afrotherian species. The yolk sac floats freely in the exocoelom in at least one tenrec 
species, the Nimba otter shrew (Micropotamogale lamottei) (67), in another Afrotherian 
insectivore, the eastern rock elephant shrew (Elephantulus myurus) (68) and in two 
species of bat (Myotis lucifugus (little brown bat) (69) and Tadarida brasiliensis (70)). 
These observations suggest that both mouse and human yolk sacs reflect convergent 
evolution toward similar forms found elsewhere in the mammalian phylogenetic tree. The 
yolk sac of the chicken, of course, is characteristic of oviparous species: all birds and the 
majority of reptiles. 
 
Under a classic Darwinian model of macroevolution, small genetic mutations gradually 
occur and are accompanied by correspondingly small phenotypic changes until, over 
time, a high degree of morphological and functional diversification accumulates between 
species that are distantly related. The results presented here suggest, however, that the 
genetic systems underlying the function of the yolk sac are robust. We identify a number 
of genetic modules, including those involved in cholesterol processing, lipid transport, 
redox processes and nutrient delivery which were presumably reorganized and 
redeployed during evolutionary change while being internally conserved. These findings 
are in line with an extended evolutionary-developmental model in which it is the gene 
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regulatory networks and underlying transcriptional control elements which change (71). 
The repeated convergent evolution of yolk sac placentas in all major groups of 
vertebrates other than birds is characteristic of what has come to be known as deep 
homology which describes the origin of complex structures through modification and 
reorganization of pre-existing genetic systems (72). Given that the modular conservation 
of systems active in the yolk sac is shown to extend across mammals and birds, the 
common ancestor of which was a reptile, it is possible that genetic modules of the yolk 
sac are part of the core amniote genetic repertoire. That is, conserved genetic systems 
of yolk sac function, for example cholesterol and lipid metabolism, form part of the 
common heritage shared by all mammals, reptiles and birds, and are the building blocks 
for both oviparous and viviparous reproductive modes.  
 
Our findings indicate that extensive high level morphological diversification of the 
extraembryonic membranes masks a surprising degree of functional conservation at the 
molecular genetic level. Evolutionary conservation at the level of nucleotide sequence, 
gene regulation and modularity of gene expression is widely regarded as evidence of 
functional significance in both healthy development and in disease (73-75). Therefore, 
we propose, that although a choriovitelline placenta is never established physically in the 
human, the early placental villi, the exocoelomic cavity and the secondary yolk sac 




Human tissue collection 
Tissue and fluid samples were collected with informed written patient consent and 
approval of the Joint UCL/UCLH Committees on the Ethics of Human Research 
(05/Q0505/82) from 7-12 weeks in uncomplicated pregnancies. Gestational age was 
confirmed by ultrasound measurement of the crown rump length of the embryo. All 
samples were collected from patients undergoing surgical pregnancy termination under 
general anesthesia for psycho-social reasons. Coelomic fluid samples were obtained by 
transvaginal puncture under sonographic guidance as previously described (27). Villous 
samples were obtained under transabdominal ultrasound guidance from the central 
region of the placenta using a chorionic villus sampling (CVS) technique. Intact 
secondary yolk sacs were obtained by gentle aspiration guided by ultrasound. All 
samples were snap frozen in liquid nitrogen and stored at -80°C until analysis. 
 
Mouse tissue collection 
Yolk sacs were collected from time-mated virgin C57BL/6J mice. Experiments were 
carried out in accordance with the United Kingdom Animals Scientific Procedures Act 
1986 which mandates ethical review. A single randomly selected yolk sac was collected 
from each pregnant female at E9.5 (day of plug = E0.5). Tissue was dissected free from 
decidua and amnion, snap frozen and stored at -80°C until processing. 
 
RNA extraction and RNA-Seq 
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RNA from human and mouse yolk sacs and human first trimester placental villi was 
extracted using RNeasy plus universal mini kit (Qiagen, Cat No 73404). Libraries were 
made using the Illumina TruSeq Stranded mRNA library kit according to the 
manufacturer’s instructions. Libraries were quantified (kappa qPCR) and equimolar pools 
sequenced (single end 50 base reads, SE50) in several lanes of the Illumina HiSeq2500. 
Additional details are provided in the Supplemental Information. 
 
Data availability  
The data sets generated during the current study are available in the European 
Nucleotide Archive (ENA http://www.ebi.ac.uk/ena) under the accession number 
PRJEB18767, http://www.ebi.ac.uk/ena/data/view/PRJEB18767. 
 
Proteomic analysis of coelomic fluid samples 
Coelomic fluid samples were run on 1D gels, enzymatically digested and analyzed using 
LC-MS/MS (Dionex Ultimate 3000 RSLC nanoUPLC, Thermo Fisher Scientific Inc, 
Waltham, MA, USA) system and a QExactive Orbitrap mass spectrometer (Thermo 




Immunohistochemistry was performed as previously described (76) using the following 








This study was supported by the Medical Research Council (MR/L020041/1). We would 
like to thank Prof Kathryn Lilley (University of Cambridge) for the proteomic analysis and 
Dr. Erica Watson (University of Cambridge) for assistance with the mouse yolk sac 




T.C-D., E.J., G.J.B. and D.S.C.-J. designed the study. 
T.C.-D., E.J. and S.G. performed the experiments. 
T.C.-D., G.J.B. and D.S.C.-J. wrote the manuscript with contributions from E.J., M.G.E. 
and S.G. 
All authors analyzed data. 
All authors edited and approved the final manuscript 
 
Competing financial interests  
	 13	
The authors declare no competing financial interests. 
 
Corresponding author: 




1. Mossman, H. (1987) Vertebrate fetal membranes: comparative ontogeny and 
morphology: evolution; phylogenetic significance; basic finctions, research 
opportunities (Macmillan, London). 
2. Brent, R. L. & Fawcett, L. B. (1998) Nutritional studies of the embryo during early 
organogenesis with normal embryos and embryos exhibiting yolk sac dysfunction. 
J Pediatr 132:S6-16. 
3. Woollett, L. A. (2008) Where does fetal and embryonic cholesterol originate and 
what does it do? Annu Rev Nutr 28:97-114. 
4. Baardman, M. E., Erwich, J. J., Berger, R. M., Hofstra, R. M., Kerstjens-
Frederikse, W. S., et al. (2012) The origin of fetal sterols in second-trimester 
amniotic fluid: endogenous synthesis or maternal-fetal transport? Am J Obstet 
Gynecol 207:202 e219-225. 
5. Baardman, M. E., Kerstjens-Frederikse, W. S., Berger, R. M., Bakker, M. K., 
Hofstra, R. M., et al. (2013) The role of maternal-fetal cholesterol transport in 
early fetal life: current insights. Biol Reprod 88:24. 
6. King, B. F. & Enders, A. C. (1970) Protein absorption and transport by the guinea 
pig visceral yolk sac placenta. Am J Anat 129:261-287. 
7. Moore, K. (1988) The Developing Human Clinically Oriented Embryology (WB 
Saunders Company, Harcourt Brace Jovanovich, Inc., Philadelphia, London, 
Toronto, Montreal, Sydney, Tokyo). 
8. Zohn, I. E. & Sarkar, A. A. (2010) The visceral yolk sac endoderm provides for 
absorption of nutrients to the embryo during neurulation. Birth Defects Res A Clin 
Mol Teratol 88:593-600. 
9. Jauniaux, E., Gulbis, B., & Burton, G. J. (2003) The human first trimester 
gestational sac limits rather than facilitates oxygen transfer to the foetus--a 
review. Placenta 24 Suppl A:S86-93. 
10. Jones, C. (1997) in Embryonic medicine and therapy, eds. Jaunaiux, E., Barnea, 
E., & Edwards, R. (Oxford University Press, Oxford). 
11. Porn, M. I., Ares, M. P., & Slotte, J. P. (1993) Degradation of plasma membrane 
phosphatidylcholine appears not to affect the cellular cholesterol distribution. J 
Lipid Res 34:1385-1392. 
12. Fielding, C. J. & Fielding, P. E. (2004) Membrane cholesterol and the regulation 
of signal transduction. Biochem Soc Trans 32:65-69. 
13. Porter, J. A., Young, K. E., & Beachy, P. A. (1996) Cholesterol modification of 
hedgehog signaling proteins in animal development. Science 274:255-259. 
14. Cooper, M. K., Wassif, C. A., Krakowiak, P. A., Taipale, J., Gong, R., et al. (2003) 
A defective response to Hedgehog signaling in disorders of cholesterol 
biosynthesis. Nat Genet 33:508-513. 
15. Marti, E. & Bovolenta, P. (2002) Sonic hedgehog in CNS development: one 
signal, multiple outputs. Trends Neurosci 25:89-96. 
16. Long, J., Tokhunts, R., Old, W. M., Houel, S., Rodgriguez-Blanco, J., et al. (2015) 
Identification of a family of fatty-acid-speciated sonic hedgehog proteins, whose 
members display differential biological properties. Cell Rep 10:1280-1287. 
17. Witsch-Baumgartner, M., Gruber, M., Kraft, H. G., Rossi, M., Clayton, P., et al. 
(2004) Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. 
J Med Genet 41:577-584. 
18. Burke, K. A., Jauniaux, E., Burton, G. J., & Cindrova-Davies, T. (2013) 
Expression and immunolocalisation of the endocytic receptors megalin and 
cubilin in the human yolk sac and placenta across gestation. Placenta 34:1105-
1109. 
	 15	
19. Xiao, C., Hsieh, J., Adeli, K., & Lewis, G. F. (2011) Gut-liver interaction in 
triglyceride-rich lipoprotein metabolism. Am J Physiol Endocrinol Metab 
301:E429-446. 
20. Adkins, J. N., Varnum, S. M., Auberry, K. J., Moore, R. J., Angell, N. H., et al. 
(2002) Toward a human blood serum proteome: analysis by multidimensional 
separation coupled with mass spectrometry. Mol Cell Proteomics 1:947-955. 
21. Jauniaux, E., Gulbis, B., Jurkovic, D., Campbell, S., Collins, W. P., et al. (1994) 
Relationship between protein concentrations in embryological fluids and maternal 
serum and yolk sac size during human early pregnancy. Hum Reprod 9:161-166. 
22. Jauniaux, E. & Gulbis, B. (2000) Fluid compartments of the embryonic 
environment. Human Reproduction Update 6:268-278. 
23. Jones, C. J. P. & Jauniaux, E. (1995) Ultrastructure of the materno-embryonic 
interface in the first trimester of pregnancy. Micron 26:145-173. 
24. Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M. (2015) SLC transporters as 
therapeutic targets: emerging opportunities. Nat Rev Drug Discov 14:543-560. 
25. Jauniaux, E., Gulbis, B., Gerlo, E., & Rodeck, C. (1998) Free amino acid 
distribution inside the first trimester human gestational sac. Early Hum Dev 
51:159-169. 
26. Contempre, B., Jauniaux, E., Calvo, R., Jurkovic, D., Campbell, S., et al. (1993) 
Detection of thyroid hormones in human embryonic cavities during the first 
trimester of pregnancy. J Clin Endocrinol Metab 77:1719-1722. 
27. Jauniaux, E., Sherwood, R. A., Jurkovic, D., Boa, F. G., & Campbell, S. (1994) 
Amino acid concentrations in human embryological fluids. Hum Reprod 9:1175-
1179. 
28. Campbell, J., Wathen, N., Macintosh, M., Cass, P., Chard, T., et al. (1992) 
Biochemical composition of amniotic fluid and extraembryonic coelomic fluid in 
the first trimester of pregnancy. Br J Obstet Gynaecol 99:563-565. 
29. Jauniaux, E., Jurkovic, D., Gulbis, B., Gervy, C., Ooms, H. A., et al. (1991) 
Biochemical composition of exocoelomic fluid in early human pregnancy. Obstet 
Gynecol 78:1124-1128. 
30. Jauniaux, E., Hempstock, J., Teng, C., Battaglia, F. C., & Burton, G. J. (2005) 
Polyol concentrations in the fluid compartments of the human conceptus during 
the first trimester of pregnancy: maintenance of redox potential in a low oxygen 
environment. J Clin Endocrinol Metab 90:1171-1175. 
31. Gulbis, B., Jauniaux, E., Decuyper, J., Thiry, P., Jurkovic, D., et al. (1994) 
Distribution of iron and iron-binding proteins in first-trimester human pregnancies. 
Obstet Gynecol 84:289-293. 
32. Wathen, N. C., Delves, H. T., Campbell, D. J., & Chard, T. (1995) The coelomic 
cavity--a reservoir for metals. Am J Obstet Gynecol 173:1884-1888. 
33. Campbell, J., Wathen, N., Perry, G., Soneji, S., Sourial, N., et al. (1993) The 
coelomic cavity: an important site of materno-fetal nutrient exchange in the first 
trimester of pregnancy. Br J Obstet Gynaecol 100:765-767. 
34. Campbell, J., Wathen, N. C., Merryweather, I., Abbott, R., Muller, D., et al. (1994) 
Concentrations of vitamins A and E in amniotic fluid, extraembryonic coelomic 
fluid, and maternal serum in the first trimester of pregnancy. Arch Dis Child Fetal 
Neonatal Ed 71:F49-50. 
35. Iles, R. K., Wathen, N. C., Sharma, K. B., Campbell, J., Grudzinskas, J. G., et al. 
(1994) Pregnancy-associated plasma protein A levels in maternal serum, 
extraembryonic coelomic and amniotic fluids in the first trimester. Placenta 
15:693-699. 
	 16	
36. Vallee, B. L. & Falchuk, K. H. (1993) The biochemical basis of zinc physiology. 
Physiol Rev 73:79-118. 
37. Kambe, T., Hashimoto, A., & Fujimoto, S. (2014) Current understanding of ZIP 
and ZnT zinc transporters in human health and diseases. Cell Mol Life Sci 
71:3281-3295. 
38. Jauniaux, E., Cindrova-Davies, T., Johns, J., Dunster, C., Hempstock, J., et al. 
(2004) Distribution and transfer pathways of antioxidant molecules inside the first 
trimester human gestational sac. J Clin Endocrinol Metab 89:1452-1459. 
39. Gulbis, B., Jauniaux, E., Cotton, F., & Stordeur, P. (1998) Protein and enzyme 
patterns in the fluid cavities of the first trimester gestational sac: relevance to the 
absorptive role of secondary yolk sac. Mol Hum Reprod 4:857-862. 
40. Evans, P., Cindrova-Davies, T., Muttukrishna, S., Burton, G. J., Porter, J., et al. 
(2011) Hepcidin and iron species distribution inside the first-trimester human 
gestational sac. Mol Hum Reprod 17:227-232. 
41. Wathen, N. C., Cass, P. L., Campbell, D. J., Kitau, M. J., & Chard, T. (1992) 
Levels of placental protein 14, human placental lactogen and unconjugated 
oestriol in extraembryonic coelomic fluid. Placenta 13:195-197. 
42. Burton, G. J., Watson, A. L., Hempstock, J., Skepper, J. N., & Jauniaux, E. (2002) 
Uterine glands provide histiotrophic nutrition for the human fetus during the first 
trimester of pregnancy. J Clin Endocrinol Metab 87:2954-2959. 
43. Hempstock, J., Cindrova-Davies, T., Jauniaux, E., & Burton, G. J. (2004) 
Endometrial glands as a source of nutrients, growth factors and cytokines during 
the first trimester of human pregnancy: a morphological and 
immunohistochemical study. Reprod Biol Endocrinol 2:58. 
44. Jauniaux, E., Gulbis, B., Hyett, J., & Nicolaides, K. H. (1998) Biochemical 
analyses of mesenchymal fluid in early pregnancy. Am J Obstet Gynecol 
178:765-769. 
45. Castellucci, M. & Kaufmann, P. (1982) A three-dimensional study of the normal 
human placental villous core: II. Stromal architecture. Placenta 3:269-285. 
46. Baron, M. H., Vacaru, A., & Nieves, J. (2013) Erythroid development in the 
mammalian embryo. Blood Cells Mol Dis 51:213-219. 
47. Tavian, M. & Peault, B. (2005) The changing cellular environments of 
hematopoiesis in human development in utero. Exp Hematol 33:1062-1069. 
48. Palis, J. & Yoder, M. C. (2001) Yolk-sac hematopoiesis: the first blood cells of 
mouse and man. Exp Hematol 29:927-936. 
49. Luckett, W. P. (1978) Origin and differentiation of the yolk sac and 
extraembryonic mesoderm in presomite human and rhesus monkey embryos. 
Am J Anat 152:59-97. 
50. Tavian, M., Hallais, M. F., & Peault, B. (1999) Emergence of intraembryonic 
hematopoietic precursors in the pre-liver human embryo. Development 126:793-
803. 
51. Burk, R. F. & Hill, K. E. (2005) Selenoprotein P: an extracellular protein with 
unique physical characteristics and a role in selenium homeostasis. Annu Rev 
Nutr 25:215-235. 
52. Wooding, F. & Flint, A. (1994) in Marshall's Physiology of Reproduction, ed. 
Lamming, G. (Chapman & Hall, London). 
53. Wooding, F. P. & Burton, G. J. (2008) Comparative Placentation. Structures, 
Functions and Evolution (Springer, Berlin). 
54. Lloyd, J. B., Beckman, D. A., & Brent, R. L. (1998) Nutritional role of the visceral 
yolk sac in organogenesis-stage rat embryos. Reprod Toxicol 12:193-195. 
	 17	
55. Carter, A. M. (2016) IFPA Senior Award Lecture: Mammalian fetal membranes. 
Placenta 48 Suppl 1:S21-S30. 
56. Burton, G. J., Hempstock, J., & Jauniaux, E. (2001) Nutrition of the human fetus 
during the first trimester--a review. Placenta 22 Suppl A:S70-77. 
57. Pereda, J., Correr, S., & Motta, P. M. (1994) The structure of the human yolk sac: 
a scanning and transmission electron microscopic analysis. Arch Histol Cytol 
57:107-117. 
58. Yadgary, L., Wong, E. A., & Uni, Z. (2014) Temporal transcriptome analysis of 
the chicken embryo yolk sac. BMC Genomics 15:690. 
59. Hoyes, A. D. (1969) The human foetal yolk sac. An ultrastructural study offour 
specimens. Z Zellforsch Mikrosk Anat 99:469-490. 
60. Hesseldahl, H. & Larsen, J. F. (1969) Ultrastructure of human yolk sac: 
endoderm, mesenchyme, tubules and mesothelium. Am J Anat 126:315-335. 
61. Nogales, F., Beltran, E., & Gonzales, F. (1993) in The human yolk sac and yolk 
sac tumors (Springer, Berlin, Heidelberg). 
62. Blackburn, D. G. (1992) Convergent Evolution of Viviparity, Matrotrophy, and 
Specializations for Fetal Nutrition in Reptiles and Other Vertebrates. Amer. Zool. 
32:313-321. 
63. Dulvy, N. & Reynolds, J. (1997) Evolutionary transition among egg-laying, live-
bearing and maternal inputs in sharks and rays. Proceedings of the Royal 
Society B: Biological Sciences 264(1386):1309-1315. 
64. Stewart, J. (1993) Yolk Sac Placentation in Reptiles: Structural Innovation in a 
Fundamental Vertebrate Fetal Nutritional System. J Exp Zool 266:431-449. 
65. Enders, A. C. (1960) Development and structure of the villous haemochorial 
placenta of the nine-banded armadillo (Dasypus novemcinctus). J Anat 94:34-45. 
66. King, B. F. & Wilson, J. M. (1983) A fine structural and cytochemical study of the 
rhesus monkey yolk sac: endoderm and mesothelium. Anat Rec 205:143-158. 
67. Carter, A. M., Blankenship, T. N., Enders, A. C., & Vogel, P. (2006) The fetal 
membranes of the otter shrews and a synapomorphy for afrotheria. Placenta 
27:258-268. 
68. Oduor-Okelo, D., Katema, R. M., & Carter, A. M. (2004) Placenta and fetal 
membranes of the four-toed elephant shrew, Petrodromus tetradactylus. 
Placenta 25:803-809. 
69. Enders, A. C., Wimsatt, W. A., & King, B. F. (1976) Cytological development of 
yolk sac endoderm and protein-absorptive mesothelium in the little brown bat, 
Myotis lucifugus. Am J Anat 146:1-30. 
70. Stephens, R. J. & Cabral, L. J. (1971) Cytological differentiation of the 
mesothelial cells of the yolk sac of the bat, Tadarida brasiliensis cynocephala. 
Anat Rec 171:293-312. 
71. Carroll, S. B. (2008) Evo-devo and an expanding evolutionary synthesis: a 
genetic theory of morphological evolution. Cell 134:25-36. 
72. Shubin, N., Tabin, C., & Carroll, S. (2009) Deep homology and the origins of 
evolutionary novelty. Nature 457:818-823. 
73. Boffelli, D., Nobrega, M. A., & Rubin, E. M. (2004) Comparative genomics at the 
vertebrate extremes. Nat Rev Genet 5:456-465. 
74. Stewart, J. B., Freyer, C., Elson, J. L., & Larsson, N. G. (2008) Purifying selection 
of mtDNA and its implications for understanding evolution and mitochondrial 
disease. Nat Rev Genet 9:657-662. 
75. Woolfe, A., Goodson, M., Goode, D. K., Snell, P., McEwen, G. K., et al. (2005) 
Highly conserved non-coding sequences are associated with vertebrate 
development. PLoS Biol 3:e7. 
	 18	
76. Cindrova-Davies, T., Yung, H. W., Johns, J., Spasic-Boskovic, O., Korolchuk, S., 
et al. (2007) Oxidative Stress, Gene Expression, and Protein Changes Induced in 
the Human Placenta during Labor. Am J Pathol 171:1168-1179. 
77. Martin, M. (2016) Cutadapt removes adapter sequences from high-throughput 
sequencing reads. doi 10.14806/ej.17.1.200. 
78. Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., et al. (2013) TopHat2: 
accurate alignment of transcriptomes in the presence of insertions, deletions and 
gene fusions. Genome Biol 14:R36. 
79. Anders, S., Pyl, P. T., & Huber, W. (2015) HTSeq--a Python framework to work 
with high-throughput sequencing data. Bioinformatics 31:166-169. 
80. Love, M. I., Huber, W., & Anders, S. (2014) Moderated estimation of fold change 
and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. 
81. Fagerberg, L., Hallstrom, B. M., Oksvold, P., Kampf, C., Djureinovic, D., et al. 
(2014) Analysis of the human tissue-specific expression by genome-wide 
integration of transcriptomics and antibody-based proteomics. Mol Cell 
Proteomics 13:397-406. 
82. Mi, H., Muruganujan, A., & Thomas, P. D. (2013) PANTHER in 2013: modeling 
the evolution of gene function, and other gene attributes, in the context of 
phylogenetic trees. Nucleic Acids Res 41:D377-386. 
83. Walter, W., Sanchez-Cabo, F., & Ricote, M. (2015) GOplot: an R package for 
visually combining expression data with functional analysis. Bioinformatics 
31:2912-2914. 
84. Wang, M., Zhao, Y., & Zhang, B. (2015) Efficient Test and Visualization of Multi-
Set Intersections. Sci Rep 5:16923. 
85. Benjamini, Y. & Hochberg, Y. (1995) Controlling the False Discovery Rate: A 
Practical and Powerful Approach to Multiple Testing. J Royal Stat Society Series 
B 57(1):289-300. 
86. Mele, M., Ferreira, P. G., Reverter, F., DeLuca, D. S., Monlong, J., et al. (2015) 
Human genomics. The human transcriptome across tissues and individuals. 
Science 348:660-665. 
87. Jauniaux, E., Jurkovic, D., Henriet, Y., Rodesch, F., & Hustin, J. (1991) 
Development of the secondary human yolk sac: correlation of sonographic and 
anatomical features. Hum Reprod 6:1160-1166. 
 
Figure Legends 
Figure 1  Chord plot illustrating the GO biological process terms that include “cholesterol” 
and that are overrepresented in the 400 most abundant yolk sac transcripts on the right, 
and the genes contributing to that enrichment on the left arranged in order of their 
expression level. 
 
Figure 2  Chord plot illustrating proteins present in the coelomic fluid that relate to GO 
biological process terms involving “cholesterol” and “lipid transport”. The presence of 
these proteins is consistent with the high level of their transcripts in the human yolk sac 
illustrated in Figure 1. 
 
Figure 3  Immunolocalization of ABCA1 and SLC39A7/ZIP7 transporter proteins in the 
human yolk sac at 11 weeks gestational age. Sections were immunostained with anti-
ABCA1 or anti-ZIP7 antibodies. In both cases, staining was present in the inner 
endodermal and outer mesothelial layers, although it was stronger in the former. 
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Figure 4  Venn diagram comparing the most abundant 400 transcripts in the human yolk 
sac, with first trimester placental villi and adult liver, lung and kidney. Transcripts shared 
by all five tissues (83) encoded principally housekeeping proteins, whereas those shared 
uniquely with liver (35) encoded proteins involved in cholesterol and lipid metabolism, 
suggesting the yolk sac may perform these functions while the fetal liver develops. By 
contrast, there are few transcripts shared uniquely with the kidney (5) suggesting the 
yolk sac plays little role in excretion. 
 
Figure 5  Chord plot connecting GO Biological Process terms associated with “lipid 
metabolism” and genes encoding transcripts that are shared by the human yolk sac and 
adult liver. The overlap suggests the yolk sac may perform hepatic functions while the 
fetal liver differentiates. 
 
Figure 6  Venn diagrams illustrating the overlap among overrepresented GO terms 
associated with the 400 most abundant transcripts in each of the human, mouse and 
chicken yolk sacs:  A, “biological process”; B, “cellular component” and C, “molecular 
function”. The considerable overlap among the species in all three categories suggests 
conservation of functions. 
 
Figure 7  Diagrammatic comparison of the nutrient pathway during early pregnancy in 
the mouse (A), and the speculated pathway in the human (B). In the mouse, histotrophic 
secretions (green) released from the endometrial glands (EG) are phagocytosed (1) by 
the endodermal cells (E) of the visceral layer of the inverted yolk sac (YS). Following 
fusion with lysosomes (2), digestion of maternal proteins leads to release of amino acids 
that are transported (3) to the fetal circulation (FC). In the human, histotrophic secretions 
are released from the endometrial glands through the developing basal plate of the 
placenta into the intervillous space (IVS), and are phagocytosed (1) by the 
syncytiotrophoblast (STB) (ref. 42). We speculate that following digestion by lysosomal 
enzymes (2), free amino acids are transported (3) by efflux transporters to the coelomic 
fluid (CF) where they accumulate. Nutrients in the CF may be taken up by the 
mesothelial cells (M) of the yolk sac and transported (4) into the fetal circulation (FC). 
Alternatively, they may diffuse into the cavity of the yolk sac and be taken up by the 
endodermal cells (5). Some intact maternal proteins may also be released into the CF by 
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RNA-Seq reveals conservation of function among the yolk sacs of 
human, mouse and chicken 
 





Proteomics.  1D gel lanes were cut into 8 bands and each band was transferred into a 96-
well PCR plate.  The bands were cut into 1mm2 pieces, destained, reduced (DTT) and 
alkylated (iodoacetamide) and subjected to enzymatic digestion with trypsin overnight at 37°C.  
After digestion, the supernatant was pipetted into a sample vial and loaded onto an 
autosampler for automated LC-MS/MS analysis. 
 
All LC-MS/MS experiments were performed using a Dionex Ultimate 3000 RSLC nanoUPLC 
(Thermo Fisher Scientific Inc, Waltham, MA, USA) system and a QExactive Orbitrap mass 
spectrometer (Thermo Fisher Scientific Inc, Waltham, MA, USA).  Separation of peptides was 
performed by reverse-phase chromatography at a flow rate of 300 nL/min and a Thermo 
Scientific reverse-phase nano Easy-spray column (Thermo Scientific PepMap C18, 2µm 
particle size, 100Å pore size, 75µm i.d. x 50cm length).  Peptides were loaded onto a pre-
column (Thermo Scientific PepMap 100 C18, 5µm particle size, 100Å pore size, 300µm i.d. x 
5mm length) from the Ultimate 3000 autosampler with 0.1% formic acid for 3 minutes at a flow 
rate of 10 µL/min.  After this period, the column valve was switched to allow elution of peptides 
from the pre-column onto the analytical column.  Solvent A was water + 0.1% formic acid and 
solvent B was 80% acetonitrile, 20% water + 0.1% formic acid.  The linear gradient employed 
was 2-40% B in 30 minutes. 
 
The LC eluant was sprayed into the mass spectrometer by means of an Easy-Spray source 
(Thermo Fisher Scientific Inc.).  All m/z values of eluting ions were measured in an Orbitrap 
mass analyzer, set at a resolution of 70000 and was scanned between m/z 380-1500.  Data 
dependent scans (Top 20) were employed to automatically isolate and generate fragment ions 
by higher energy collisional dissociation (HCD, NCE:25%) in the HCD collision cell and 
measurement of the resulting fragment ions was performed in the Orbitrap analyser, set at a 
resolution of 17500.  Singly charged ions and ions with unassigned charge states were 
excluded from being selected for MS/MS and a dynamic exclusion window of 20 seconds was 
employed. 
 
Post-run, the data was processed using Protein Discoverer (version 1.4., ThermoFisher).  
Briefly, all MS/MS data were converted to mgf files and the files were then submitted to the 
Mascot search algorithm (Matrix Science, London UK) and searched against the UniProt 
human database (153168 sequences; 54677058 residues).  Variable modifications of 
oxidation (M) and deamidation (NQ) and a fixed modification of carbamidomethyl (C) were 
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applied and the peptide and fragment mass tolerances were set to 5ppm and 0.1 Da, 
respectively.  A significance threshold value of p<0.05 and a peptide cut-off score of 20 were 
also applied.  All the Mascot data from each lane was merged to give a single output file. 
Finally, Mascot .dat files were entered into the Scaffold software (Proteome Software, Oregon 
USA) so that differences between the two protein samples could be compared. 
 
Two samples had very few recognizable peptide hits these samples were excluded from the 
subsequent analysis.  Unique hits to identifiable proteins were counted and those with the 
same gene name in the identifier filed combined.  The corresponding gene names for the 





RNA-Seq data processing 
Quality assessment and trimming of the de-multiplex reads was carried out using FastQC and 
cutadapt respectively (http://www.bioinformatics.babraham.ac.uk/projects/fastqc(1).  The 
trimmed short reads were mapped to the human reference genome (hg19) using TopHat2 
(version 2.0.12), a splice-aware mapper(2).  Uniquely mapped reads were counted using 




To compare the levels of transcripts in the yolk sac and placental villi with those in the liver, 
lung and kidney processed RNA-Seq data was down loaded from the EBI Expression Atlas 
(version: 0.1.4-SNAPSHOT, experiment E-MTAB-513 
http://www.ebi.ac.uk/gxa/experiments/E-MTAB-513?ref=aebrowse).  
 
To compare with 27 other tissues processed RNA-Seq data was downloaded from 




The most abundant 400 transcripts in the tissues of interest were identified (ranked by mean 
RPKM) and gene ontology analyzed by using Panther(6) (http://pantherdb.org release 
20160715).  The complete Panther data base was used to include the mitochondrially 
encoded transcripts.  The Biological Process, Molecular Function and Cellular Component 
were all analyzed.  The reference sets were all Homo sapiens or Mus musculus genes (known 
in Panther) and the Bonferroni correction for multiple testing was applied in all cases. 
Chord plots of enriched GO terms (Figure 1 for example) were generated in R using GOplot 
(v 1.0.2. available from CRAN) (7). 
 
Venn diagrams 
Venn diagrams were generated in R (vennCounts and VennDiagram, within the Bioconductor 
limma package) and the p-values for the observed overlaps calculated with SuperExactTest 
by Wang et al 2015 (v 0.99.2, available from CRAN)(8). 
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Transcription factor binding sites 
Within the most abundant 400 transcripts in the human yolk sac, 19 genes are annotated as 
"regulation of transcription, DNA-templated" (GO:0006355) including several transcription 
factors (ATF4, FOS, FOSB, JUN, JUNB and JUND XBP-1 and BHLHE40). In the mouse 8 
genes were similarly annotated (Table S3.) 
 
The correlation (Spearman) between each of the transcripts encoding these transcription 
factors and all other yolk sac transcripts (rpkm >15) was calculated.  The transcripts with rho 
>0.8 were identified.  Over-represented transcription factor binding motifs in these genes were 
identified (JASPAR2016 and TFBSTools).  Candidate motifs recognized by the transcription 
factors (or family for JUN and FOS) were enriched in the 1kb and 5kb upstream of the TSS of 
the highly correlated genes.  Regions of interest were extracted using Biostrings and 
transcription factor binding motifs identified using JASPAR2016 and TFBSTools, all in R.  P 
values were corrected for multiple testing(9) (Datasets S7 & 8). 
 
Similar analysis was carried out for the mouse data in which 8 genes were annotated as 
above.  Atf4 was the only transcription factor with a binding motif in the JASPAR2016 
database.  Candidate motifs recognized by Atf4 were enriched in the 1kb and 5kb upstream 
of the TSS of the highly correlated genes (Datasets S9 &10). 
 





Sample quality control 
Hierarchical clustering of the yolk sac reads indicated that 1 sample did not cluster with any 
other sample and formed a separate branch.  This sample had extremely high levels of villous 
specific transcripts (CGA, CGB, CGB5, CGB8, PSG1, PSG2, PSG3, PSG4, PSG9, LEP, 
KISS1 and CSH2; for example CGA ~73,000 vs a mean of ~320 for the other samples).  It is 
therefore likely that the sample is contaminated with villous material.  This sample was 
removed and the level of these transcripts examined in the remaining samples.  Two additional 
samples had markedly different levels of these transcripts and so were also excluded from 
subsequent analysis.  
 
RNASeq data from the first trimester villus samples were similarly processed and 1 sample 
clustered alone as a well separated branch.  This sample had higher levels of decidual 
transcripts (such as IGF2, IGFPB4, IGFPB5, IGFPB7 and low levels of villous transcripts 
(CGA, CGB, CGB5, LEP and KISS1).  This sample was therefore excluded from subsequent 
analysis.  
 
A similar approach was adopted with the mouse yolk sac samples and 1 sample clustered as 
a well-separated branch.  This sample had much lower levels of the fetal hemoglobin 
transcripts (Hbb-y, Hbb-bh1 and Hba-x) whereas these were the most abundant in all the other 




Various enriched GO terms are associated with mitochondrial activity (“mitochondrial 
respiratory chain complex”, and “mitochondrial ATP synthesis coupled electron transport” for 
example).  This is consistent with the previously reported high density of mitochondria in the 
yolk sac(10).  We calculated the proportion of transcripts present that were encoded by the 
mitochondrial genome (Figure S1).  The fractions for the yolk sac and first trimester villi are 
slightly above the average and these data are consistent with that showing the kidney and 




Figure S1.  The fraction of mitochondrially encoded transcripts in each tissue type is the 
proportion mitochondrial genes over the sum over all RPKM values in that tissue 
 
Mitochondrially encoded transcripts directly involved in the electron transfer chain and (or) 
energy generation were highly correlated with each other (Spearman’s rho >0.71) and not with 
other transcripts in the most abundant 400 (Datasets S6).  One other transcript was correlated 
with these (HNRNPA2B1).  Other mitochondrially encoded transcripts (12S and 16S rRNA) 
were not similarly correlated. 
 
Comparison with other tissues. 
We used hierarchical clustering to examine the relationships among the expression patterns 
of the most variable transcripts detected at rpkm ≥ 0.1 in the yolk sac, placental villi and a 
range of other tissues.  As previously reported, clustering recapitulated the origin of the 
tissue(5).  The first trimester placental villi and the term placental samples clustered together 
with the yolk sac cluster forming an adjacent branch (Figure S2).  This indicates the first and 
third trimester villi have similar transcript profiles and the 3 extra-embryonic tissues are more 
similar to each other than to the other tissues examined.  The yolk sac samples form 2 closely 
































































































































a marked difference in the level of transcripts encoding ALB, AFP, HBE, HBZ.  It is known 
from previous studies that the size of the yolk sac declines from a maximum diameter of ~6mm 
at approximately 10 weeks gestation (12).  The gestational age of the samples used in this 
study is only available for a subset of the samples.  However, for those where this is known 
the samples obtained earlier in gestation (7+0, 8+2, 9+0 and 9+2) are on a separate branch 





Figure S2.  Hierarchical clustering of multiple tissues based on the 500 transcripts with the 
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Figure S3 a & b. 
Chord plots illustrating the proteins annotated with the GO molecular function and cellular 








































Human Yolk sac  Human first trimester villi  Mouse yolk sac 
Sample ID Reads  Sample ID Reads  Sample ID Reads 
YS167 48,834,289  P270 4,058,853  B6YS1.2 36,961,551 
YS7 63,379,887  P325 23,438,297  B6YS3.1 16,745,203 
YS9 58,695,200  P392 12,959,581  B6YS9.1 24,340,906 
YS10 65,310,562  P393 58,672,011  B6YS10.1 15,963,038 
YS11 37,760,671  P118 76,386,477  B6YS11.1 64,903,212 
YS3 39,471,048  P272 205,189,675  B6YS24.1 20,101,598 
YS4 28,688,319  P274 30,427,351  B6YS27.1 32,624,089 
YS5 33,224,068  P275 131,727,903  B6YS28.1 36,481,077 
YS155 39,022,547  P179 22,238,388    
   P327 89,441,895    
        
median 39,471,048  median 30,427,351  median 28,482,498 
 
Summary of the number of RNASeq reads (single-end 50base) obtained for the human and 
mouse yolk sacs and the first trimester human placental villi. 
 
Table S2 
Common circulating blood 
proteins 
Serum albumin, Afamin (albumin family, vit E-binding), Ig 
(κC, γ-1,-2, λ, V-II, V-III), Apolipoproteins (A-I, A-II, A-IV, 
B, B100, D, E, M), clusterin (apolipoprotien J), heparan 
sulfate proteoglycan (basement-membrane-specific), 
α-2-macroglobulin, Hemopexin (β-1B-glycoprotein), α-1B-
glycoprotein, α-2-HS-glycoprotein, α-1-acid 
glycoprotein, Gelsolin, Fibrinogen α, Vitronectin, Zinc-
α-2-glycoprotein, Histidine-rich glycoprotein, β-2-
microglobulin, α-1-acid glycoprotein, Leucine-rich α-2-




Complement (B, C3, C4, C7, C9, D, H, I), Kininogen, 
Coagulation factors (V, XII) 
Blood transport and binding 
proteins 
Serotransferrin, Ceruloplasmin, Transthyretin, Vitamin D-
binding protein, Retinol-binding protein, Galectin-3-
binding protein, Latent-transforming growth factor beta-
binding protein, Phospholipid transfer protein, Hemoglobin 
(α, β, ε, ζ ), Thyroxine-binding globulin, Insulin-like 
growth factor-binding protein 3, Latent-transforming 
growth factor β-binding protein, Corticosteroid-binding 
globulin 
Protease inhibitors α-1-antitrypsin, Antithrombin-III, α-1-antichymotrypsin, 
Inter-α-trypsin inhibitor, Plasma protease C1 inhibitor, 
Inter-α-trypsin inhibitor, α-2-antiplasmin, Cystatin c 
(potent inhibitor of lysosomal proteinases), Heparin 
cofactor 2 (rapidly inhibits thrombin in the presence of 
dermatan sulfate or heparin), inhibits trypsin, plasmin, and 
lysosomal granulocytic elastase), Metalloproteinase 
inhibitor 1 
	 8	
Proteases and other 
enzymes 
Plasminogen, angiotensinogen, Procollagen C-
endopeptidase enhancer, Glutathione peroxidase, 
Prothrombin, Cu-Zn superoxide dismutase, 
Cytokines and hormones α-fetoprotein, Pigment epithelium-derived factor (serpin 1), 






Fibronectin, Fibulin-1, Decorin (proteoglycan), Collagens-
α1, -2,-3, Laminin, Versican core protein, Periostin, 
Keratins (I, II), Transforming growth factor-β-induced 
protein, Lumican (proteoglycan), Laminin (β1, γ1), 
glycodelin, Hyaluronan and proteoglycan link protein, 
nidogen-1 (entactin, basement memb), titin (striated 
muscle contraction), actin, Fibulin-2, Osteonectin (SPARC, 
a glycoprotein in the bone that binds calcium), Spondin-1 
(axon guidance), Extracellular matrix protein 1, 
Dystroglycan (dystrophin-associated glycoprotein), 
Cadherin-1 (transmembrane protein) 
Proteins in bold are also reported in human serum 
 












ENSG00000065978	 YBX1	 Y	box	binding	protein	1	 IDA	
ENSG00000128272	 ATF4	 activating	transcription	factor	4	 IEA,	ISS	
ENSG00000145741	 BTF3	 basic	transcription	factor	3	 IEA	







ENSG00000152795	 HNRNPDL	 heterogeneous	nuclear	ribonucleoprotein	D-like	 IEA	
ENSG00000171223	 JUNB	 jun	B	proto-oncogene	 IEA	
ENSG00000130522	 JUND	 jun	D	proto-oncogene	 IEA	
ENSG00000177606	 JUN	 jun	proto-oncogene	 IEA	
ENSG00000107438	 PDLIM1	 PDZ	and	LIM	domain	1	 IEA	
ENSG00000177469	 PTRF	 polymerase	I	and	transcript	release	factor	 IEA	
ENSG00000149273	 RPS3	 ribosomal	protein	S3	 IEA	




ENSG00000107223	 EDF1	 endothelial	differentiation-related	factor	1	 TAS	
ENSG00000089009	 RPL6	 ribosomal	protein	L6	 TAS	
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ENSG00000134107	 BHLHE40	 basic	helix-loop-helix	family,	member	e40	 NAS	
ENSG00000167244	 IGF2	 insulin-like	growth	factor	2	(somatomedin	A)	 NAS	
	    






ENSMUSG00000042406	 Atf4	 activating	transcription	factor	4	 IDA,	IMP	
ENSMUSG00000006932	 Ctnnb1	 catenin	(cadherin	associated	protein),	beta	1	 IDA	
ENSMUSG00000020267	 Hint1	 histidine	triad	nucleotide	binding	protein	1	 IEA,	ISS,	ISO	
ENSMUSG00000028639	 Ybx1	 Y	box	protein	1	 IEA,	ISS,	ISO	
ENSMUSG00000021660	 Btf3	 basic	transcription	factor	3	 IEA	
ENSMUSG00000051223	 Bzw1	 basic	leucine	zipper	and	W2	domains	1	 IEA	





Table of the genes annotated with the GO term “regulation of transcription, DNA-templated" 
(GO:0006355) in the most abundant human and mouse yolk sac transcripts.  GO evidence 








BP BP description MF MF description CC CC description 
GO:0006364 rRNA processing GO:0003676 nucleic acid binding GO:0000323 lytic vacuole 






ribosome GO:0005576 extracellular region 
GO:0006807 
nitrogen compound 
metabolic process GO:0005198 
structural molecule 
activity GO:0005615 extracellular space 
GO:0008152 metabolic process GO:0005488 binding GO:0005622 intracellular 
GO:0009058 biosynthetic process GO:0016491 
oxidoreductase 
activity GO:0005623 cell 
GO:0009059 
macromolecule 








metabolic process GO:0097159 
organic cyclic 
compound binding GO:0005739 mitochondrion 
GO:0009987 cellular process GO:1901363 
heterocyclic 
compound binding GO:0005740 mitochondrial envelope 
GO:0010467 gene expression   GO:0005746 mitochondrial respiratory chain 
GO:0016072 
rRNA metabolic 
process   GO:0005764 lysosome 
GO:0019538 
protein metabolic 
process   GO:0005773 vacuole 
GO:0022613 
ribonucleoprotein 




process   GO:0005840 ribosome 
GO:0034645 
cellular macromolecule 
biosynthetic process   GO:0005912 adherens junction 
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GO:0042254 ribosome biogenesis   GO:0005924 cell-substrate adherens junction 
GO:0042255 ribosome assembly   GO:0005925 focal adhesion 
GO:0043043 
peptide biosynthetic 
process   GO:0015934 large ribosomal subunit 
GO:0043603 
cellular amide 
metabolic process   GO:0015935 small ribosomal subunit 
GO:0043604 
amide biosynthetic 
process   GO:0016020 membrane 
GO:0044085 
cellular component 
biogenesis   GO:0022625 cytosolic large ribosomal subunit 
GO:0044237 
cellular metabolic 
process   GO:0022626 cytosolic ribosome 
GO:0044238 
primary metabolic 
process   GO:0022627 cytosolic small ribosomal subunit 
GO:0044249 
cellular biosynthetic 
process   GO:0030054 cell junction 
GO:0044267 
cellular protein 




process   GO:0030529 intracellular ribonucleoprotein complex 
GO:0044281 
small molecule 
metabolic process   GO:0031090 organelle membrane 
GO:0044710 
single-organism 
metabolic process   GO:0031966 mitochondrial membrane 
GO:0055114 
oxidation-reduction 
process   GO:0031982 vesicle 
GO:0065003 
macromolecular 
complex assembly   GO:0031988 membrane-bounded vesicle 
GO:0071704 
organic substance 









process   GO:0043227 membrane-bounded organelle 
GO:1901576 
organic substance 
biosynthetic process   GO:0043228 non-membrane-bounded organelle 
    GO:0043229 intracellular organelle 
    GO:0043230 extracellular organelle 
    GO:0043231 intracellular membrane-bounded organelle 
    GO:0043232 
intracellular non-membrane-bounded 
organelle 
    GO:0044391 ribosomal subunit 
    GO:0044421 extracellular region part 
    GO:0044422 organelle part 
    GO:0044424 intracellular part 
    GO:0044444 cytoplasmic part 
    GO:0044445 cytosolic part 
    GO:0044446 intracellular organelle part 
    GO:0044455 mitochondrial membrane part 
    GO:0044464 cell part 
    GO:0070062 extracellular exosome 
    GO:0070161 anchoring junction 
    GO:0070469 respiratory chain 
    GO:0098798 mitochondrial protein complex 
    GO:0098800 
inner mitochondrial membrane protein 
complex 
    GO:1903561 extracellular vesicle 
 
Over represented GO terms shared among the 400 most abundant transcripts in the human, mouse and chicken yolk sacs.  BP, Biological 
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